BioCentury | Oct 3, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: September 2018

...Salk Institute for Biological Studies Preclinical News Transcription factor AP-2 α (TFAP2A; TFAP2) Endocrine/metabolic Metabolic Argininosuccinate lyase (ASL)...
BioCentury | Sep 10, 2018
Distillery Therapeutics


...determining the timing and level of gene modulation required in patients with the disease. TARGET/MARKER/PATHWAY: Argininosuccinate lyase (ASL)...
Items per page:
1 - 2 of 2